IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion

New Zealand Medical Journal

Volumn 109, Issue 1021, 1996, Pages 156-159

  Rasat, Rahmah ^a   Livesey, John L ^b   Espiner, Eric A ^a,d   Abbott, George D ^a   Donald, Richard A ^c  

^a Paediatric Endocrinology ^*

^b Christchurch Hospital

^c UNIVERSITY OF OTAGO   (New Zealand)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; FEMALE; GROWTH DISORDER; HUMAN; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ACROMEGALY; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0030578030     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995; 80: 1532-40.
2. Clemmons DR, Judson J, Van Wyk MD, et al. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979; 301: 1138-42.
3. Rieu M, Girard F, Bricaire H, Binoux M. The importance of insulin like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. J Clin Endocrinol Metab 1982; 55: 147-53.
4. Ho KKY, Weissberger AJ. Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy. Clin Endocrinol 1994; 41: 75-83.
5. Moore DC, Ruvalcaba RHA, Smith EK, Kelley VC. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents. Horm Res 1982; 16: 49-56.
6. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL. Insulin-like growth factors 1 and 11 in evaluation of growth retardation. J Pediatr 1986; 109: 428-33.
7. de Boer H, Blok G-J, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Rev 1995; 16: 63-86.
8. Blum WF, Ranke MB. Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3. Acta Paediatr Scand 1990; 367: 55-62.
9. Jorgensen JOL, Blum WF, Moller N, Ranke MB, Christiansen JS. Circadian patterns of serum insulin-like growth factor (IGF) 11 and IGF binding protein 3 in growth hormone-deficient patients and age-and sex-matched normal subjects. Acta Endocrinologica (Copenh) 1990; 123: 267-62.
10. Baxter RC and Martin JL. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986; 78: 1504-12.
11. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimuunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-8.
12. Gil-Ad I, Topper E, Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet 1979; 2: 278-80.
13. Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41: 511-6.
14. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Statistics Med 1992; 11: 1305-19.
15. Durrleman S, Simon R. Flexible regression models with cubic splines. Statistics Med 1989; 8: 551-61.
16. Box GEP, Cox DR. An analysis of transformations. J Roy Statistical Soc 1964; 26: 211-52.
17. Blethen SL, Compton P, Lippe BM, Rosenfeld RG, August GP, Johanson A. Factors predicting the response to growth hormone (GH) therapy in prepubertal children with growth hormone deficiency. J Clin Endocrinol Metab 1993; 76: 574-9.
18. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins; biological actions. Endocrine Rev 1995: 16; 3-34.
19. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patiente. Clin Endocrinol 1994; 41: 85-93.
20. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet 1994; 343: 1064-8.
21. Blum WF, Ranke MB. Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm Res 1990; 33: 31-7.
22. Jorgensen JOL, Moller N, Moller J, Weeke J, Blum WF. Insulin-like growth factor (IGF)-1 and -11 and IGF binding protein -1, -2 and -3 in patients with acromegaly before and after adenomectomy. Metabolism 1994; 43: 579-83.